Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyzing Short Interest in Carlisle Companies A Peer Comparison

Elaine Mendonca by Elaine Mendonca
March 6, 2024
in Breaking News
0
Finance_ blue chart
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

The latest data on short interest for Carlisle Companies (NYSE: CSL) shows a significant increase of 23.02% since the previous report on March 6, 2024. This surge has resulted in 716 thousand shares being sold short, which represents 1.71% of all available regular shares for trading.

Traders would require approximately 2.05 days to cover their short positions based on the current trading volume. This information is crucial as it provides insight into market sentiment towards the stock. An increase in short interest typically indicates bearishness, while a decrease suggests bullishness among investors.

When comparing Carlisle Companies’ short interest to its peers in the multi-sector conglomerates sector, it is evident that the company has a notable short interest ratio. This peer comparison is a valuable tool for evaluating a company’s performance by analyzing similar companies in terms of industry, size, age, and financial structure.

By conducting this analysis, investors and analysts can gain a better understanding of how Carlisle Companies stacks up against its peers in the market. Overall, the rise in short interest for Carlisle Companies reflects shifting market sentiment and can offer valuable insights into how traders view the stock’s future performance relative to its competitors.

CSL Stock Shows Strong Performance with 0.64% Rise – March 6, 2024

On March 6, 2024, CSL stock displayed strong performance as it traded near the top of its 52-week range and above its 200-day simple moving average. The price of CSL shares increased by $2.27 since the market last closed, representing a 0.64% rise. The stock opened at $357.86, which was $2.39 higher than its previous close. Investors may be drawn to CSL for its strong price momentum and consistent performance. It is important for investors to consider the overall market conditions and any relevant news or events that may impact CSL’s stock performance.

CSL Stock Performance Analysis: Revenue and Net Income Decline in 2024

On March 6, 2024, CSL stock experienced a mixed performance based on the financial data provided by CNN Money. The company reported a total revenue of $4.59 billion for the past year, which represents a 30.46% decrease compared to the previous year. However, the total revenue remained flat since the last quarter at $1.13 billion.

Similarly, CSL’s net income for the past year was reported at $683.10 million, showing a 25.89% decrease from the previous year. The net income also decreased by 11.52% since the last quarter to $191.30 million.

Earnings per share (EPS) for CSL were $13.55 for the past year, indicating a 22.81% decrease from the previous year. The EPS held flat since the last quarter at $2.51.

Overall, CSL’s financial performance on March 6, 2024, reflected a decline in total revenue, net income, and earnings per share compared to the previous year. However, the company managed to maintain its revenue and EPS at the same level since the last quarter.

Investors and analysts may interpret these results as a sign of stability in CSL’s financial performance, despite the year-over-year declines. It will be essential for CSL to focus on strategies to improve its revenue and profitability in the coming quarters to regain investor confidence and drive stock performance.

Tags: CSL
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Home Construction Stock Market Today

Concrete Pumping Holdings NASDAQ BBCP Prepares for Quarterly Earnings Report

Finance_ stocks to buy

Earnings Preview Runway Growth Finance Corp NASDAQ RWAY March 7 2024

Finance_Commercial (2)

Analyst Ratings and Price Targets Surge for Absci NASDAQABSI on March 6 2024

Recommended

Baidu Stock

Baidu’s Strategic Moves in Autonomous Driving and AI Draw Mixed Investor Reactions

1 month ago

Windtree Therapeutics Achieves Financial Stability and Advances Clinical Programs

2 years ago
Technology Data analytics Stock Bull Market

Anticipation High for Adobes FirstQuarter Financial Results and AI Innovation

2 years ago
Ideaya Biosciences Stock

Ideaya Biosciences: A Tale of Market Skepticism and Clinical Promise

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

Is Darden Restaurants Facing a Critical Test?

Critical Juncture for USA Rare Earth as Earnings and Chinese Export Curbs Collide

AES Shares Surge on Potential $38 Billion Acquisition Speculation

Kura Oncology Investors Await Crucial FDA Verdict

Cadence Design Stock: A Battle Between Fundamentals and Market Signals

Trending

DuPont de Nemours Stock
Analysis

DuPont Faces Critical Test as Quarterly Results Loom

by Dieter Jaworski
November 6, 2025
0

DuPont de Nemours finds itself at a pivotal moment as the chemical giant prepares to release quarterly...

Sarepta Therapeutics Stock

Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure

November 6, 2025
Emerson Electric Stock

Emerson Electric’s Strategic Pivot Faces Market Scrutiny

November 6, 2025
Lanzatech Global Stock

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

November 6, 2025
Darden Restaurants Stock

Is Darden Restaurants Facing a Critical Test?

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • DuPont Faces Critical Test as Quarterly Results Loom
  • Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure
  • Emerson Electric’s Strategic Pivot Faces Market Scrutiny

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com